Correct - it commenced just after Imugene acquired the license to Azer-cel (see page 3-4 of the company's half year report ending Dec 2023). Preliminary data from these trials are expected in H2 2024.Preliminary data from a Phase 1b trial is typically released at an interim point during the trial when enough data has been gathered to provide early insights, but before the trial is fully complete. This interim data helps stakeholders understand the drug’s potential and guides future research and development decisions. However, I must admit the presentation that Dr Shah gave at iwCAR-T 2024 seemed a little concerning
IMU Price at posting:
5.1¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)